MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,108,223 | +349.5% | 71,355 | +272.8% | 0.01% | +600.0% |
Q2 2023 | $691,528 | +16.3% | 19,140 | +19.7% | 0.00% | 0.0% |
Q1 2023 | $594,508 | -17.9% | 15,990 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $724,507 | -88.8% | 15,990 | -82.7% | 0.00% | -87.5% |
Q3 2022 | $6,468,000 | +4.0% | 92,617 | 0.0% | 0.02% | +6.7% |
Q2 2022 | $6,218,000 | -18.3% | 92,617 | 0.0% | 0.02% | 0.0% |
Q1 2022 | $7,615,000 | -43.5% | 92,617 | +0.8% | 0.02% | -42.3% |
Q4 2021 | $13,479,000 | -1.9% | 91,890 | +18.3% | 0.03% | -10.3% |
Q3 2021 | $13,747,000 | +74.1% | 77,707 | +59.0% | 0.03% | +81.2% |
Q2 2021 | $7,894,000 | +72.4% | 48,872 | +82.8% | 0.02% | +60.0% |
Q1 2021 | $4,579,000 | +3.8% | 26,737 | +33.2% | 0.01% | 0.0% |
Q4 2020 | $4,410,000 | -14.7% | 20,074 | -35.5% | 0.01% | -23.1% |
Q3 2020 | $5,167,000 | +90.7% | 31,108 | +31.1% | 0.01% | +85.7% |
Q2 2020 | $2,710,000 | +32.8% | 23,734 | -10.5% | 0.01% | 0.0% |
Q1 2020 | $2,040,000 | +446.9% | 26,532 | +814.9% | 0.01% | +600.0% |
Q4 2019 | $373,000 | – | 2,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |